Sergio Carmona1, Trevor Peter, Leigh Berrie. 1. aNational Health Laboratory Services, University of the Witwatersrand bClinton Health Access Initiative cWits Health Consortium, Johannesburg, South Africa.
Abstract
PURPOSE OF REVIEW: In 2015, the WHO urged countries to provide ART to all people living with HIV, irrespective of their CD4 cell count, this new recommendation supports the Joint United Nations Programme on HIV/AIDS elimination targets. However, to meet these aims, urgent scale-up of viral load testing is critical. The multiple interventions in the healthcare system required to support scale-up of viral load testing are reviewed here. RECENT FINDINGS: It is estimated that 18.2 million individuals are accessing antiretroviral therapy, consequently this will cause significant demand for viral load monitoring; however, at the current rate of implementation, demand will not meet the required target by 2020. To change this trajectory, multiple stakeholders must be involved, communities and key populations need increased treatment literacy to create demand and greater numbers of healthcare workers will require training. In addition, laboratories and point-of-care testing sites will need to be expanded, and adequate monitoring and evaluation tools will need to be put in place to identify gaps in the system, to institute prompt corrective actions and to direct resources where needed. SUMMARY: Sufficient scale-up of viral load may well be possible if innovations in mHealth are used to support healthcare workers and patients with regard to the scale-up and effective use of viral load monitoring; new laboratory technologies are implemented, both at a centralized level and point-of-care, to manage higher volumes and improve coverage; and there is careful coordination between implementing partners and funders.
PURPOSE OF REVIEW: In 2015, the WHO urged countries to provide ART to all people living with HIV, irrespective of their CD4 cell count, this new recommendation supports the Joint United Nations Programme on HIV/AIDS elimination targets. However, to meet these aims, urgent scale-up of viral load testing is critical. The multiple interventions in the healthcare system required to support scale-up of viral load testing are reviewed here. RECENT FINDINGS: It is estimated that 18.2 million individuals are accessing antiretroviral therapy, consequently this will cause significant demand for viral load monitoring; however, at the current rate of implementation, demand will not meet the required target by 2020. To change this trajectory, multiple stakeholders must be involved, communities and key populations need increased treatment literacy to create demand and greater numbers of healthcare workers will require training. In addition, laboratories and point-of-care testing sites will need to be expanded, and adequate monitoring and evaluation tools will need to be put in place to identify gaps in the system, to institute prompt corrective actions and to direct resources where needed. SUMMARY: Sufficient scale-up of viral load may well be possible if innovations in mHealth are used to support healthcare workers and patients with regard to the scale-up and effective use of viral load monitoring; new laboratory technologies are implemented, both at a centralized level and point-of-care, to manage higher volumes and improve coverage; and there is careful coordination between implementing partners and funders.
Authors: Paul K Drain; Jienchi Dorward; Andrew Bender; Lorraine Lillis; Francesco Marinucci; Jilian Sacks; Anna Bershteyn; David S Boyle; Jonathan D Posner; Nigel Garrett Journal: Clin Microbiol Rev Date: 2019-05-15 Impact factor: 26.132
Authors: Julie Hubbard; Gift Kakwesa; Mike Nyirenda; James Mwambene; Ashley Bardon; Kelvin Balakasi; Kathryn Dovel; Thokozani Kalua; Risa M Hoffman Journal: Int Health Date: 2019-05-01 Impact factor: 2.473
Authors: Sheree R Schwartz; Matthew M Kavanagh; Jeremy Sugarman; Sunil S Solomon; Illiassou M Njindam; Kevin Rebe; Thomas C Quinn; Coumba Toure-Kane; Chris Beyrer; Stefan Baral Journal: J Int AIDS Soc Date: 2017-11 Impact factor: 5.396
Authors: Victor Ssempijja; Larry W Chang; Gertrude Nakigozi; Anthony Ndyanabo; Thomas C Quinn; Frank Cobelens; Maria Wawer; Ronald Gray; David Serwadda; Steven J Reynolds Journal: Open Forum Infect Dis Date: 2018-10-09 Impact factor: 3.835
Authors: Mastula Nanfuka; Jamie I Forrest; Wendy Zhang; Stephen Okoboi; Josephine Birungi; Pontiano Kaleebu; Julia Zhu; Samuel Tibenganas; David M Moore Journal: Medicine (Baltimore) Date: 2021-05-14 Impact factor: 1.889
Authors: Maria Ruano Camps; Paula E Brentlinger; Gerito Augusto; Alexandre Nguimfack; Florindo Mudender Journal: J Int Assoc Provid AIDS Care Date: 2017-05-31
Authors: Trevor Peter; Clement Zeh; Zachary Katz; Ali Elbireer; Bereket Alemayehu; Lara Vojnov; Alex Costa; Naoko Doi; Ilesh Jani Journal: J Int AIDS Soc Date: 2017-11 Impact factor: 5.396